| Document Date: 2012-11-04 10:30:58
Open Document File Size: 49,63 KBShare Result on Facebook
City Birmingham / Cambridge / Cagliari / / Company Novartis / Novirio / Idenix Pharmaceuticals / GlaxoSmithKline / Merck / IHL Press / Cox / / Continent Asia / Europe / / Country Italy / Belgium / France / United States / China / / Currency USD / / Event FDA Phase / Person Travel / Name Change / Business Partnership / / Facility University of Montpelier II / University of Montpellier / University of Alabama / DALI University / University of Oran / / IndustryTerm pharmaceutical industry / HBV therapeutics / pharmaceuticals / HBV treatment / therapies for hepatitis B / / MedicalCondition chronic carriers / herpes viruses / HIV / HBV / liver failure / typically blood-borne disease / hepatitis C / hepatitis B / needle stick injury / e.g. cirrhosis / hepatitis / illness / liver disease / HBV viremia / cancer / HBV infection / tumors / disease / hepatocellular carcinoma / hepatitis B. the / HCV / chronic infections / HBV infections / infection / chronic hepatitis B / / Organization University of Oran in Algeria / DALI University in China / University of Alabama / FDA / University of Montpellier / European Union / / Person Jean Louis Imbach / David Standring / Sommadossi / Fellow / Gilles Gosselin / / Position physician / co-author / Scientist / doctoral supervisor / still CNRS Research Director / assistant professor / Major / founder / / Product Hepsera / PegIntron / Epivir-HBV / Tyzeka / Pegasys / lamivudine / Viread / Roferon A / Intron A / Baraclude / EU / / ProvinceOrState Alabama / Massachusetts / / URL http /
SocialTag |
Inventor file Gilles Gosselin